Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Lilly Directs Zepbound self-pay vials run ~$499/month, or ~$5,988/year)
Mucinex D
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes
The medication was found to also result in weight loss, and it is now FDA-approved for the treatment of diabetes and obesity management. Due to a shortage of these popular medications, compounding pharmacies were temporarily authorized to manufacture and sell GLP-1 drugs
It is usually very well-tolerated, with fewer side effects reported by some patients
US$ 29.21
US$ 21.61
US$ 25.20
US$ 22.58
US$ 25.19
US$ 25.49
US$ 26.96
